Detalhe da pesquisa
1.
In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma.
Mol Ther
; 22(1): 81-91, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24025749
2.
Silencing human genetic diseases with oligonucleotide-based therapies.
Hum Genet
; 132(5): 481-93, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23494242
3.
Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1.
Mol Biol Cell
; 16(7): 3223-35, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15872091
4.
Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.
Cancer Res
; 68(20): 8221-30, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18922893
5.
Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
Exp Cell Res
; 294(2): 571-80, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15023543
6.
Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion.
Blood
; 102(6): 1978-84, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12775566
7.
The chemokine stromal cell-derived factor-1 alpha modulates alpha 4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin.
J Immunol
; 168(10): 5268-77, 2002 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11994484